Results 31 to 40 of about 348,699 (383)

Efficacy of Phototherapy With 308-nm Excimer Light for Skin Microbiome Dysbiosis and Skin Barrier Dysfunction in Canine Atopic Dermatitis

open access: yesFrontiers in Veterinary Science, 2021
The management of canine atopic dermatitis, an allergic skin disorder, is challenging. To investigate the effect of phototherapy using a 308-nm excimer light as a topical treatment for canine atopic dermatitis, 10 dogs with canine atopic dermatitis and ...
Ju-Yong Park   +2 more
doaj   +1 more source

Allergic march in children: Atopic dermatitis in Japanese children with bronchial asthma

open access: yesAllergology International, 1996
Atopic diseases in children often develop in series and atopic dermatitis usually occurs first. To clarify the serial development of atopic dermatitis and bronchial asthma in atopic children in Japan, the present and/or past history of atopic dermatitis ...
Mitsufumi Mayumi   +7 more
doaj   +1 more source

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial

open access: yesDermatology and Therapy, 2020
Introduction Patients with atopic dermatitis (AD) have a greater risk of conjunctivitis and other ocular surface disorders than the general population. We evaluated the burden of ocular surface disorders and related symptoms prior to treatment initiation
Jonathan Weyne   +7 more
doaj   +1 more source

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

open access: yesJAMA dermatology, 2021
Key Points Question What is the short-term efficacy and safety of oral abrocitinib in adolescents with moderate-to-severe atopic dermatitis? Findings In the randomized clinical trial JADE TEEN, a phase 3 study of abrocitinib in combination with topical ...
L. Eichenfield   +14 more
semanticscholar   +1 more source

Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
BACKGROUND: atopic dermatitis is directly related to psychological stress, reduced quality of life and psychosomatic symptoms. The Psychosomatic Scale for Atopic Dermatitis is the only questionnaire developed specifically for assessment of ...
Manuela Boleira   +5 more
doaj   +1 more source

Proderm technology: a water- based lipid delivery system for dermatitis that penetrates viable epidermis and has antibacterial effects. [PDF]

open access: yes, 2019
BackgroundA defective skin barrier and bacterial colonization are two important factors in maintenance and progression of atopic dermatitis and chronic allergic/irritant hand dermatitis.
Caputo-Janhager, Melinda   +4 more
core   +3 more sources

Use of the complex of models of regression for analysis of the factors that determine the severity of bronchial asthma [PDF]

open access: yes, 2020
Background: According to an International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence of asthma in children of 6-7 years old has increased by 10%, and at the age of 13-14 years by 16% over the last decade.
Kozhyna, Olga S., Pihnastyi, O. M.
core   +1 more source

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
Atopic dermatitis (AD) is a common inflammatory skin condition that has traditionally been considered a paradigmatic type 2 immunity (T2)‐driven disease.
T. Bieber
semanticscholar   +1 more source

Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. [PDF]

open access: yes, 2019
Chronic itch remains a highly prevalent disorder with limited treatment options. Most chronic itch diseases are thought to be driven by both the nervous and immune systems, but the fundamental molecular and cellular interactions that trigger the ...
Barton, Gregory M   +11 more
core   +1 more source

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

open access: yesJAMA dermatology, 2020
This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
J. Silverberg   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy